Skip to content

The Comparison of 50% AS Versus PFAT+ 0.05 % COE in Severe Dry Eye Syndrome

The Comparison of 50 % Concentration Autologous Serum Eye Drops Versus Preservative Free Artificial Eye Drop Plus 0.05 % Cyclosporin Ophthalmic Emulsion in the Treatment of Severe Dry Eye Syndrome: A Randomized Comparative Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03666884
Enrollment
36
Registered
2018-09-12
Start date
2015-10-10
Completion date
2016-10-25
Last updated
2018-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Syndrome

Keywords

dry eye, autologous serum, cyclosporine ophthalmic emulsion

Brief summary

The present study aimed to evaluate and compare the efficacy of a 1 month clinical trial of 50% AS for the treatment of severe dry eye syndrom (DES) based on Schirmer's Test, tear break-up time (TBUT), fluorescein staining, and ocular surface disease index (OSDI) scores, as compared to conventional preservative-free artificial tears (PFAT) plus 0.05% COE treatment in patients with severe DES

Detailed description

This is an retrospective comparative study. The designation of the patient whether to use AS 8\*1 or conventional PFAT 8\*1 plus COE 2\*1 was determined randomly. Student's paired samples t-test, independent samples Student's t-test, Wilcoxon signed-rank test and Mann-Whitney U test were used to compare data. All patients responded well to both treatments after the first 1-month treatment period, based on comparison of before and after treatment OSDI scores, Schirmer's test results, TBUT values, and OXFORD scale scores.

Interventions

DRUGCOE 2*1 (Restasis) + PFAT Refresh Single dose) 8*1

clinical improvement in oxford scale, ocular surface disease index, schirmers test, tear break up time, fluorescein staining of eye

BIOLOGICALAS 50% eye drops 8*1

clinical improvement in oxford scale, ocular surface disease index, schirmers test, tear break up time, fluorescein staining of eye

Sponsors

Usak State Hospital
CollaboratorOTHER
Seref istek
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participants chose their treatment regime randomly

Intervention model description

The comparison of 50 % concentration autologous serum eye drops versus preservative free artificial eye drop plus 0.05 % cyclosporin ophthalmic emulsion in the treatment of severe dry eye syndrom

Eligibility

Sex/Gender
ALL
Age
40 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* refractory to conventional treatment (those that did not respond well to entire dry eye medications containing hydroxypropyl methylellulose, carboxyl methylcellulose, polyvinyl alcohol, polyethylene glycol-propylene glycol, sodium hyaluronate, mineral oil, dextran, and carbomer artificial tears with or without preservatives) * had low TBUT (\< 5 s) (5μL of fluorescein sodium 2% eye drops was used) * low Schirmer's test I score without topical anesthesia ( basic+reflex secretion), positive corneal and conjunctival fluorescein staining (≥grade 1 according to the OXFORD Scale) (3) and an OSDI score \> 40 OSDI was a reliable and valid test for quantifying the severity of dry eye symptoms

Exclusion criteria

* active ocular infection or any other inflammation not associated with dry eye * a severe associated ocular allergy, eyelid or eyelash abnormality * current contact lens use, history of refractive surgery * associated glaucoma * current use of any type of topical eye drops other than dry eye medications * any known graft-versus host disease * known severe anemia (hemoglobin\<11 g/dL-1) * medically uncontrolled significant cerebrovascular and cardiovascular disease * pregnant and lactating patients

Design outcomes

Primary

MeasureTime frameDescription
schirmers test 1 resultfirst month results after two treatment regimes for severe dry eye groupes, 5 minutes tear drop wetness of schirmers paper in milimetersclinical improvement in schirmer's test 1 result
ocular surface oxford scalefirst month results after two treatment regimes for severe dry eye groupes, dry eye symptom scale graded 1 to 4clinical improvement in oxford scale
ocular surface disease index scale (OSDI)first month results after two treatment regimes for severe dry eye groupes, dry eye symptoms graduation prepared with sample questions concluded in 2 digit numbers from 25 to 100,clinical improvement in OSDI
tear break up timefirst month results after two treatment regimes for severe dry eye groupes, dry eye quantitave assesment of tear break up time in seconds graded from 0 sec to 10 seconds 10 the best 0 the worstclinical improvement in tear break up time
fluorescein staining of eyefirst month results after two treatment regimes for severe dry eye groupes, graduation of dry eye clinical examination graded from 1 to 4clinical improvement in fluorescein staining of eye

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026